Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Feng Chen, Yu Yang, Chunxue Fang, Jincheng Zhao, Mei Han, Qiushuang Zhu, Xue Bai, Mingyuan Liu & Guangyuan Yang. (2015) Effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of clopidogrel in rats. Xenobiotica 45:12, pages 1122-1128.
Read now
Read now
James C Coons, Nicholas Schwier, Justin Harris & Amy L Seybert. (2014) Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 609-620.
Read now
Read now
S Casey Laizure & Robert B Parker. (2010) A comparison of the metabolism of clopidogrel and prasugrel. Expert Opinion on Drug Metabolism & Toxicology 6:11, pages 1417-1424.
Read now
Read now
Articles from other publishers (27)
Zhichang Zhao, Yeming Wang, Nana Tian, Hong Yan & Juan Wang. (2021)
Synthesis and biological evaluation of
N
6
derivatives of 8-azapurine as novel antiplatelet agents
. RSC Medicinal Chemistry 12:8, pages 1414-1427.
Crossref
Crossref
Yu Lei, Bing Zhang, Dan Liu, Jian Zhao, Xiwen Dai, Jun Gao, Qing Mao, Yao Feng, Jiaxing Zhao, Fengwei Lin, Yulin Duan, Yan Zhang, Ziyang Bao, Yuwei Yang, Yanhua Mou & Shaojie Wang. (2020)
Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
1
and P2Y
12
as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor
. Journal of Medicinal Chemistry 63:24, pages 15752-15772.
Crossref
Crossref
Yifang SunJessica VenugopalChiao GuoYanbo FanJianping LiYanjun GongY. Eugene ChenHaoming ZhangDaniel T. Eitzman. (2020) Clopidogrel Resistance in a Murine Model of Diet-Induced Obesity Is Mediated by the Interleukin-1 Receptor and Overcome With DT-678. Arteriosclerosis, Thrombosis, and Vascular Biology 40:6, pages 1533-1542.
Crossref
Crossref
Jun Zhang, Dandan Wang, Liwei Zou, Min Xiao, Yufeng Zhang, Ziwei Li, Ling Yang, Guangbo Ge & Zhong Zuo. (2020) Rapid bioluminescence assay for monitoring rat CES1 activity and its alteration by traditional Chinese medicines. Journal of Pharmaceutical Analysis 10:3, pages 253-262.
Crossref
Crossref
Xiaohua Li, Peng Liu, Zhiping Xu, Dong Sun, Jingkai Gu, Yujia Miao, Jujin Zhang & Xia Cao. (2020) A Pharmacodynamic Study of CN-218, a Novel Antiplatelet and Antithrombotic Agent Primarily Targeting the P2Y12 Receptor. Cardiovascular Drugs and Therapy 34:1, pages 15-23.
Crossref
Crossref
Deyu Kong, Tao Xue, Bin Guo, Jianjun Cheng, Shunyin Liu, Jianhai Wei, Zhengyu Lu, Haoran Liu, Guoqing Gong, Tian Lan, Wenhao Hu & Yushe Yang. (2019)
Optimization of P2Y
12
Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties
. Journal of Medicinal Chemistry 62:6, pages 3088-3106.
Crossref
Crossref
Marie-Claude Blais, Domenico Bianco, Robert Goggs, Alex M. Lynch, Lee Palmer, Alan Ralph & Claire R. Sharp. (2019) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 3-Defining antithrombotic protocols. Journal of Veterinary Emergency and Critical Care 29:1, pages 60-74.
Crossref
Crossref
Nan Lu, Lingjun Li, Xuemin Zheng, Shijun Zhang, Yuquan Li, Jing Yuan, Qunchao Wei, Youjun Xu & Fancui Meng. (2018) Synthesis of a Novel Series of Amino Acid Prodrugs Based on Thienopyridine Scaffolds and Evaluation of Their Antiplatelet Activity. Molecules 23:5, pages 1041.
Crossref
Crossref
H. Zhang, D. A. Lauver, H. Wang, D. Sun, P. F. Hollenberg, Y. E. Chen, Y. Osawa & D. T. Eitzman. (2016) Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis. Journal of Pharmacology and Experimental Therapeutics 359:1, pages 11-17.
Crossref
Crossref
J. Thomason, K. Lunsford & A. Mackin. (2016) Anti-platelet therapy in small animal medicine. Journal of Veterinary Pharmacology and Therapeutics 39:4, pages 318-335.
Crossref
Crossref
Yu-Han Li, Min Song & Tai-Jun Hang. (2015) Development of an LC−MS/MS method for determination of 2-oxo-clopidogrel in human plasma. Journal of Pharmaceutical Analysis 5:1, pages 12-17.
Crossref
Crossref
Katsunobu HagiharaMiho KazuiAtsushi KuriharaOsamu AndoTakashi IzumiToshihiko Ikeda. (2015) Thienopyridine P2Y12 receptor antagonists:unknown pharmacological active metabolites and metabolic activation mechanisms. Drug Delivery System 30:5, pages 454-464.
Crossref
Crossref
Liping Li, Feifeng Song, Meijuan Tu, Kai Wang, Lei Zhao, Xiaodan Wu, Hui Zhou, Zongling Xia & Huidi Jiang. (2014) In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1. International Journal of Pharmaceutics 465:1-2, pages 5-10.
Crossref
Crossref
Zhixia Qiu, Ning Li, Ling Song, Yang Lu, Jing Jing, Harendra S. Parekha, Wenchao Gao, Fengjie Tian, Xin Wang, Shuangxia Ren & Xijing Chen. (2013) Contributions of Intestine and Plasma to the Presystemic Bioconversion of Vicagrel, an Acetate of Clopidogrel. Pharmaceutical Research 31:1, pages 238-251.
Crossref
Crossref
A Sugidachi, K Ohno, T Ogawa, JA Jakubowski, M Hashimoto & A Tomizawa. (2013) A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats. British Journal of Pharmacology 169:1, pages 82-89.
Crossref
Crossref
Yaoqiu Zhu & Jiang Zhou. (2012) In Vitro Biotransformation Studies of 2-Oxo-clopidogrel: Multiple Thiolactone Ring-Opening Pathways Further Attenuate Prodrug Activation. Chemical Research in Toxicology 26:1, pages 179-190.
Crossref
Crossref
Anna Ravnefjord, Jessika Weilitz, Britt-Marie Emanuelsson & J.J.J. van Giezen. (2012) Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y12 antagonists in an ex-vivo canine model. Thrombosis Research 130:4, pages 622-628.
Crossref
Crossref
Joo Hyun Lee, Yong-Jun Shin, Ju-Hee Oh & Young-Joo Lee. (2012) Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs. Archives of Pharmacal Research 35:10, pages 1831-1837.
Crossref
Crossref
Patrick M. Dansette, Julien Rosi, Justine Debernardi, Gildas Bertho & Daniel Mansuy. (2012) Metabolic Activation of Prasugrel: Nature of the Two Competitive Pathways Resulting in the Opening of Its Thiophene Ring. Chemical Research in Toxicology 25:5, pages 1058-1065.
Crossref
Crossref
Jiaqi Shan, Boyu Zhang, Yaoqiu Zhu, Bo Jiao, Weiyi Zheng, Xiaowei Qi, Yanchun Gong, Fang Yuan, Fusheng Lv & Hongbin Sun. (2012) Overcoming Clopidogrel Resistance: Discovery of Vicagrel as a Highly Potent and Orally Bioavailable Antiplatelet Agent. Journal of Medicinal Chemistry 55:7, pages 3342-3352.
Crossref
Crossref
Bo Wiinberg, Lisbeth R. Jessen, Inge Tarnow & Annemarie T. Kristensen. (2012) Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats. Journal of Veterinary Emergency and Critical Care 22:1, pages 42-58.
Crossref
Crossref
Karsten Schrör, Jolanta M. Siller‐Matula & Kurt Huber. (2011) Pharmacokinetic basis of the antiplatelet action of prasugrel. Fundamental & Clinical Pharmacology 26:1, pages 39-46.
Crossref
Crossref
Katsunobu Hagihara, Miho Kazui, Hidenori Ikenaga, Toshihiko Nanba, Kiichi Fusegawa, Takashi Izumi, Toshihiko Ikeda & Atsushi Kurihara. (2011) The Intestine As an Important Contributor to Prasugrel Active Metabolite Formation In Vivo. Drug Metabolism and Disposition 39:4, pages 565-570.
Crossref
Crossref
Patrick M. Dansette, Stéphanie Thébault, Gildas Bertho & Daniel Mansuy. (2010) Formation and Fate of a Sulfenic Acid Intermediate in the Metabolic Activation of the Antithrombotic Prodrug Prasugrel. Chemical Research in Toxicology 23:7, pages 1268-1274.
Crossref
Crossref
Robert B. Parker & S. Casey Laizure. (2010) The Effect of Ethanol on Oral Cocaine Pharmacokinetics Reveals an Unrecognized Class of Ethanol-Mediated Drug Interactions. Drug Metabolism and Disposition 38:2, pages 317-322.
Crossref
Crossref
Katsunobu Hagihara, Miho Kazui, Atsushi Kurihara, Michiharu Yoshiike, Kokichi Honda, Osamu Okazaki, Nagy A. Farid & Toshihiko Ikeda. (2009) A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and Clopidogrel. Drug Metabolism and Disposition 37:11, pages 2145-2152.
Crossref
Crossref
Nuggehally R. Srinivas. (2009) Genetic CYP2C19 polymorphism dependent non-responders to clopidogrel therapy — Does structural design, dosing and induction strategies have a role to play?. European Journal of Drug Metabolism and Pharmacokinetics 34:3-4, pages 147-150.
Crossref
Crossref